Immune System News and Research

RSS

Researchers visualize antigen-bound T-cell receptor at atomic resolution

T cells are our immune system’s customized tools for fighting infectious diseases and tumor cells. On their surface, these special white blood cells carry a receptor that recognizes antigens.

18 Aug 2022

New method helps identify which gut microbes most likely contribute to inflammatory diseases

Cedars-Sinai investigators have developed a method to help identify which human gut microbes are most likely to contribute to a slew of inflammatory diseases like obesity, liver disease, inflammatory bowel disease, cancer and some neurological diseases.

17 Aug 2022

Immune cells preferentially use cellular waste products to power their function

The immune cells that protect us from infection and cancer seek out a wide array of fuel sources to power their function - including some long thought to be cellular waste products.

17 Aug 2022

Oral chlorophyllin supplement alleviates inflammatory bowel disease

The dietary supplement chlorophyllin alleviates inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, according to researchers from the Center for Diabetes and Metabolism Research at Sichuan University in China and from Cedars Sinai Medical Center in Los Angeles.

17 Aug 2022

Study provides insights into understanding the biology of circulating Hepatitis E variants

Over three million people are infected with the hepatitis E virus every year. So far, no effective treatment is available. An international team has investigated which factors are important for the virus in the course of its replication cycle and how it manages to maintain the infection.

17 Aug 2022

Shelter sickness: Migrants see health problems linger and worsen while waiting at the border

Two days after arriving at a temporary migrant shelter at the border with the U.S. in June, Rosa Viridiana Ceron Alpizar's 9-year-old daughter and 1-year-old son fell ill. Most of the kids in the converted gym had stomach issues after being served a meal of sausage and beans, she recalled.

17 Aug 2022

Genomic surveillance highlights the challenges posed by "shapeshifting" strains

A pioneering genomic surveillance study has provided the clearest picture yet of the arms race between Streptococcus pneumoniae, the bacterium responsible for a range of illnesses such as pneumonia and meningitis, and the vaccines designed to protect against the most dominant types. A strain called GPSC10 was found to be a particular threat, due to its increased virulence, ability to transform its structure to evade vaccines and its resistance to several common antibiotics.

17 Aug 2022

Antiviral drugs in combination with antibody therapies could help protect people from the flu pandemic

Researchers at McMaster University have found a class of well-known antiviral drugs could be part of a one-two punch to treat seasonal influenza and prevent a flu pandemic when used in combination with antibody therapies.

16 Aug 2022

Do our tonsils absorb nanoplastics?

In a new study, researchers examined if the tonsils absorb nanoplastics.

16 Aug 2022

Next generation mRNA vaccines exhibit excellent protective and therapeutic effects

Researchers around the world have been working for years on developing vaccines against different types of cancer, but without much success. Now, Tufts School of Engineering researchers think they have found one that does work. They have devised a method of targeting cancer in mice with a vaccine that is so strong and precise, it eliminates tumors and even prevents their recurrence.

16 Aug 2022

Intestinal tissue-resident lymphocytes regulate their activity depending on glucose availability

A new study led by Marc Veldhoen, group leader at the Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) and Associate Professor at Faculdade de Medicina de Lisboa (FMUL) and published today in the scientific journal PNAS (Proceedings of the National Academy of Sciences of the United States of America) discovered that white blood cells that reside in the intestines, a specific group of immune cells called tissue-resident lymphocytes, use sugar as an energy source and have a faster metabolism than lymphocytes that circulate in the blood.

15 Aug 2022

Researchers engineer artificial replicas of G protein-coupled receptors

How do signals from outside the cell cause a response inside it? Such outside signals could be hormones or neurotransmitters. To notice them, the cell's surface possesses receptors. One of the key classes of such receptors are so-called G protein-coupled receptors, or in short GPCRs.

15 Aug 2022

Immune System News and Research

Researchers visualize antigen-bound T-cell receptor at atomic resolution

New method helps identify which gut microbes most likely contribute to inflammatory diseases

Immune cells preferentially use cellular waste products to power their function

Oral chlorophyllin supplement alleviates inflammatory bowel disease

Study provides insights into understanding the biology of circulating Hepatitis E variants

Shelter sickness: Migrants see health problems linger and worsen while waiting at the border

Genomic surveillance highlights the challenges posed by "shapeshifting" strains

Antiviral drugs in combination with antibody therapies could help protect people from the flu pandemic

Do our tonsils absorb nanoplastics?

Next generation mRNA vaccines exhibit excellent protective and therapeutic effects

Intestinal tissue-resident lymphocytes regulate their activity depending on glucose availability

Researchers engineer artificial replicas of G protein-coupled receptors

Costly Chemicals; The Health and Economic Impact of 'Forever Chemicals'

Why is COVID-19 more severe in people older than 50?

People with blood-related cancers more likely to experience COVID breakthrough infections

How does COVID-19 increase clotting risk?

Study identifies multiple pathways adopted by SARS-CoV-2 to develop resistance to nirmatrelvir

Newly designed nanoparticles target the body’s immune cells to turn them against cancer

Gut microbial and immune parameters linked to heterogeneous inter-personal COVID-19 vaccine-triggered immunity

SARS-CoV-2 receptor-binding domain-based protein subunit vaccine shows promise against multiple SARS-CoV-2 variants

Understanding the DNA Damage Response in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News